Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
(Q35012174)
scientific article published on May 3, 2011
scientific article published on May 3, 2011
Language:
Current Data About
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study